In a breakthrough for patients struggling with weight management, the weight-loss drug Wegovy is now covered by Medicare and Medicaid for individuals at risk of heart disease. This new coverage means that certain prescriptions for weight-loss medications like Wegovy will be included in the list of medications covered by these federal programs.
NPR’s Scott Simon recently sat down with Dr. Disha Narang of Endeavor Health in Illinois to discuss the implications of this development. Dr. Narang emphasized the benefits of these newly covered prescriptions, highlighting how they can help patients at risk of heart disease achieve their weight-loss goals.
The decision to include Wegovy in the coverage of Medicare and Medicaid underscores the increasing recognition of the role of weight management in preventing and managing chronic health conditions. By expanding access to weight-loss medications, the coverage of Wegovy is expected to have a positive impact on public health.
This move is a significant step towards addressing the obesity epidemic in the United States and providing much-needed support to individuals struggling with weight management. As more attention is given to the importance of maintaining a healthy weight, initiatives like the coverage of Wegovy by Medicare and Medicaid will play a crucial role in supporting individuals in their journey towards better health.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”